English

23, 24 MAY
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PARTICIPANTS PROFILE

Product categories

Branded generics: 48.3%

Biological products: 34.5%

Biosimilars: 20.7%

Hospital products: 34.5%

Innovative medicines: 55.0%

more info




Partnering Strategy/Interests

In-licensing: 55.2%

Out-licensing: 46.6%

Co-marketing: 37.9%

Co-promotion: 37.9%

Co-development: 53.4%

more info




Therapeutic areas

Cardiovascular: 51.7%

CNS: 50.0%

Infectious diseases: 32.8%

Pain: 48.3%

Respiratory: 36.2%

more info



PARTICIPANTS 2019

In-licensing: 55.2%

Out-licensing: 46.6%

Co-marketing: 37.9%

Co-promotion: 37.9%

Co-development: 53.4%

Technology transfer: 28.4%

Outsourcing: 13.8%

Others: 21.6%

Sponsor

patrocinador

partner